Teva
Trending Articles
Related Content
Research & Development
Teva announces recruitment completion of Phase III clinical Study of mdc-TJK/Olanzapine LAI
Teva Pharmaceutical Industries announced the successful completion of the enrollment in the EU and US of the anticipated 640 participants of the ongoing Phase III clinical trial of mdc-TJK (TEV-44749) at the J.P. Morgan Healthcare Conference